Abstract:BACKGROUND:Acidic extracellular pH is a major feature of tumor tissue. Acid-sensing ion channels (ASICs) represent an H(+)-gated subgroup of the degenerin/epithelial Na(+) channel family and are activated by acidic microenvironment. Little is known about the expression and clinical significance of ASICs in solid tumors. The purpose of this study was to examine the expression of ASIC1 in human clear cell renal cell carcinoma (CCRCC) and to determine if the expression of ASIC1 is associated with clinicopathological features.METHODS:The expression of ASIC1 in CCRCC tissues at the mRNA and protein levels was determined by real-time quantitative polymerase chain reaction and Western blot analysis, respectively. A tissue microarray was used to assess the expression of ASIC1 protein in tumor tissue and matched adjacent normal tissues from 75 patients with CCRCC.RESULTS:ASIC1 expression was detected in normal renal and CCRCC samples. The expressions of ASIC1 protein and mRNA were significantly decreased in the CCRCC tissues compared with matched normal renal tissues (P<0.05). The staining density measurement showed that the expression of ASIC1 was significantly decreased in stage I (P=0.037), stage II (P=0.026), and stage III (P=0.026), grades I-II CCRCC (P=0.004), and CCRCC from male patients (P=0.00002). However, no significant difference was observed for ASIC1 expression between CCRCC and normal tissue in patients with stage IV CCRCC (P=0.236), patients with grades III-IV CCRCC (P=0.314), and female patients (P=0.095). Spearman correlations demonstrated that ASIC1 expression did not correlate to tumor stage (correlation coefficient [CC =0.168], P=0.149) and the age of patients (CC -0.147, P=0.688) but showed a positive correlation to higher tumor grades (CC =0.270, P=0.018).CONCLUSION:ASIC1 is downregulated in CCRCC. ASIC1 expression may be potentially used as a novel biomarker and even a CCRCC therapeutic target. Further efforts will be made to clarify the mechanism of ASIC1 in occurrence, progression, and metastasis of CCRCC.

Involvement of Acid-Sensing Ion Channel 1α in Hepatic Carcinoma Cell Migration and Invasion

ASIC1 promotes migration and invasion of hepatocellular carcinoma via the PRKACA/AP-1 signaling pathway

ASIC1a promotes acidic microenvironment-induced HCC cells migration and invasion by inducing autophagy

Involvement of Acid-Sensing Ion Channel 1a in Gastric Carcinoma Cell Migration and Invasion

ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway

CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA

ASIC1 and ASIC3 Contribute to Acidity-Induced EMT of Pancreatic Cancer Through Activating Ca 2+ /rhoa Pathway

ASIC1a contributes to the epithelial–mesenchymal transformation of breast cancer by activating the Ca2+/β‐catenin pathway

Acid-sensing ion channel 1: potential therapeutic target for tumor

Alteration of ASIC1 Expression in Clear Cell Renal Cell Carcinoma.

Inhibition of acid-sensing ion channel 1a in hepatic stellate cells attenuates PDGF-induced activation of HSCs through MAPK pathway

Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

PI3‐kinase/Akt pathway‐regulated membrane transportation of acid‐sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF‐induced HSC Activation

ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway

ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells

Suppression of Na + /H + exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion

Acid-sensing ion channel 1a mediates acid-induced increases in intracellular calcium in rat articular chondrocytes

Hepatic Stellate Cells Activated by Acidic Tumor Microenvironment Promote the Metastasis of Hepatocellular Carcinoma Via Osteopontin.

Expression and Modulation of Na(+) /H(+) Exchanger 1 Gene in Hepatocellular Carcinoma: A Potential Therapeutic Target.

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

Chloride Intracellular Channel 1 Participates in Migration and Invasion of Hepatocellular Carcinoma by Targeting Maspin